Healthy Males Clinical Trial
Official title:
Pharmacokinetics of a Novel Oral Testosterone Undecanoate Formulation With Concomitant Inhibition of 5alpha-Reductase by Finasteride
The purpose of this study is to test how the body absorbs and processes new forms of oral testosterone. Information gained during the study may help develop better forms of testosterone therapy in the future.
We will be using three drugs: The first, acyline, temporarily turns off the body's production of testosterone for about two weeks. Subjects will receive acyline as shots three times over a six-week drug administration period. During the time when the body's production of testosterone is turned off, we will give testosterone either by itself or with a medication called finasteride by mouth twice daily for one week to see how much is absorbed and present in the bloodstream after administration. Subjects will go through three one-week study drug exposure periods. During two of the three one-week study drug administration periods subjects will also take a second medication, finasteride, by mouth twice daily. On the last day of each one-week drug administration period, subjects will be admitted to the University of Washington General Clinical Research Center overnight for monitoring of your blood testosterone levels. There will be 3 overnight visits for this study. This study will allow us to determine the absorption of testosterone taken by mouth, and the relative impact of two different doses of oral finasteride on testosterone absorption. ;
Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04234594 -
Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.
|
Phase 1 | |
| Completed |
NCT01367561 -
Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function
|
Phase 1 | |
| Completed |
NCT00777543 -
Increasing Ferulic Acid Bioavailability in Bran
|
N/A | |
| Recruiting |
NCT04756635 -
Effects of Short- Term Intermittent Fasting Aerobic and Anaerobic Capacity
|
N/A | |
| Completed |
NCT02156661 -
Oxytocin and Emotion Processing
|
Phase 1 | |
| Completed |
NCT01848665 -
The Influence of Cerebral Blood Flow and PETCO2 on Neuromuscular Function During Passive Heat Stress
|
Phase 4 | |
| Completed |
NCT05294198 -
Beetroot Extract and Its Influence on Cardiovascular and Autonomic Recovery From the Effort in Healthy Males
|
N/A | |
| Completed |
NCT00839319 -
HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone
|
Phase 1/Phase 2 | |
| Completed |
NCT01847053 -
Bioavailability Study of Cinnamon in Healthy Subjects
|
Phase 1/Phase 2 | |
| Completed |
NCT01215292 -
ITT4 Intratesticular Hormonal Milieu in Man (ITT4)
|
Phase 1/Phase 2 | |
| Completed |
NCT00782392 -
Bioavailability and Dosing of a Monosaccharide Supplement in Adults
|
N/A | |
| Completed |
NCT03714685 -
Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations
|
Phase 1 | |
| Completed |
NCT05277597 -
Effect of a 4-week Post-exercise Sauna Bathing on Targeted Gut Microbiota
|
N/A | |
| Completed |
NCT01032616 -
Uptake and Utilization of Amino Acids by Splanchnic Bed
|
Phase 1 | |
| Completed |
NCT01830335 -
Cerebral Blood Flow and PETCO2 on Neuromuscular Function During Environmental Stress
|
Phase 4 | |
| Completed |
NCT00902512 -
Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations
|
Phase 4 | |
| Completed |
NCT00475371 -
A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males
|
Phase 1 | |
| Completed |
NCT01870102 -
Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR and Pelubiprofen SR (as a Pelubiprofen 45 mg) Tablet in Healthy Subjects
|
Phase 1 |